TANDEM – Tailored intervention for ANxiety and Depression Management in COPD
Principal Investigator: Professor Sally Singh
Chronic obstructive pulmonary disease (COPD) is a common long term condition and is predicted by the World Health Organisation to become fifth most important cause of disability worldwide by 2020.
Patients with COPD struggle with breathlessness, as well as an intermittent cough and increased sputum production, making it more difficult to complete daily physical tasks. This can have a huge impact on their lives and, as a result, some patients can start to feel anxious or depressed
Current NICE guidance recommends pulmonary rehabilitation for patients with COPD, which delivers supervised exercise training, together with an educational programme. The outcomes for patients have been well documented and include reduced breathlessness, increased exercise capacity and improved quality of life.
The aim of the TANDEM study is to investigate whether providing tailored one to one sessions with a trained respiratory healthcare professional prior to starting pulmonary rehabilitation can reduce mild to moderate anxiety and depression in these patients and go on to enhance their outcomes in the pulmonary rehabilitation programme.
Participants will be recruited to the study and then divided at random into the TANDEM one to one sessions group or a standard care group (which acts as a control group). Participants in the one to one session group will have 5 to 8 appointments to discuss how they manage their COPD and how it makes them feel, both physically and emotionally. The goal of the sessions is to help them think about their problems and help to promote positive changes. Following the one to one sessions, participants will then have the option to embark on a pulmonary rehabilitation programme.
The TANDEM study is funded by the NIHR and is led by Queen Mary University of London.
This study is now closed for recruitment.
For more information about the TANDEM study please contact Grace France, TANDEM researcher on 0116 258 3035 or email email@example.com
You can read the publication of the study protocol here.